GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (HKSE:00013) » Definitions » Selling, General, & Admin. Expense

HUTCHMED (China) (HKSE:00013) Selling, General, & Admin. Expense : HK$958 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is HUTCHMED (China) Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. HUTCHMED (China)'s selling, general, & admin. expense for the six months ended in Jun. 2024 was HK$452 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jun. 2024 was HK$958 Mil.


HUTCHMED (China) Selling, General, & Admin. Expense Historical Data

The historical data trend for HUTCHMED (China)'s Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Selling, General, & Admin. Expense Chart

HUTCHMED (China) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 413.12 475.57 991.45 1,059.64 1,040.08

HUTCHMED (China) Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 625.82 438.82 534.70 506.96 451.50

Competitive Comparison of HUTCHMED (China)'s Selling, General, & Admin. Expense

For the Drug Manufacturers - Specialty & Generic subindustry, HUTCHMED (China)'s Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HUTCHMED (China)'s Selling, General, & Admin. Expense Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HUTCHMED (China)'s Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where HUTCHMED (China)'s Selling, General, & Admin. Expense falls into.



HUTCHMED (China) Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$958 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HUTCHMED (China)  (HKSE:00013) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


HUTCHMED (China) Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


HUTCHMED (China) Business Description

Address
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
Executives
Deutsche Bank Aktiengesellschaft 2303 Depositary
M&g Plc 2201 Interest of corporation controlled by you
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.
Ck Hutchison Holdings Limited 2201 Interest of corporation controlled by you
Ck Hutchison Global Investments Limited
Hutchison Whampoa (china) Limited
Hutchison Healthcare Holdings Limited

HUTCHMED (China) Headlines

No Headlines